Breaking News Instant updates and real-time market news.

GOOG

Alphabet

$1,466.88 /

+22.5 (+1.56%)

, GOOGL

Alphabet Class A

$1,460.51 /

+21.84 (+1.52%)

14:15
09/28/20
09/28
14:15
09/28/20
14:15

Google updates policies to make third-party app stores easier on Android 12

Google (GOOG) unveiled new changes to its developer policies, promising to make using third-party app stores easier on Android 12. The company said it will be making changes in Android 12, which will be next year's Android release to make it even easier for people to use other app stores on their devices while being careful not to compromise the safety measures Android has in place. "We want to be sure our policies are clear and up to date so they can be applied consistently and fairly to all developers, and so we have clarified the language in our Payments Policy to be more explicit that all developers selling digital goods in their apps are required to use Google Play's billing system," the company said. The Fly notes that this announcement comes as Apple (AAPL) and "Fortnite" maker Epic Games are embroiled in a legal dispute over Epic's attempts to offer alternate billing methods on the tech giant's App Store. Investors in Epic include Tencent (TCEHY), KKR (KKR), Disney (DIS), and Sony (SNE). Reference Link

GOOG

Alphabet

$1,466.88 /

+22.5 (+1.56%)

GOOGL

Alphabet Class A

$1,460.51 /

+21.84 (+1.52%)

AAPL

Apple

$114.60 /

+2.38 (+2.12%)

TCEHY

Tencent

$0.00 /

+ (+0.00%)

KKR

KKR

$34.90 /

+0.96 (+2.83%)

DIS

Disney

$126.41 /

+2.37 (+1.91%)

SNE

Symbol now SONY

$77.34 /

+0.05 (+0.06%)

  • 28

    Sep

GOOG Alphabet
$1,466.88 /

+22.5 (+1.56%)

09/24/20 Morgan Stanley
Alphabet price target raised to $1,800 after consumer survey at Morgan Stanley
09/18/20 Morgan Stanley
AES Corp. price target raised to $23.50 from $19 at Morgan Stanley
09/14/20 KeyBanc
Alphabet initiated with an Overweight at KeyBanc
08/25/20 UBS
Alphabet price target raised to $1,970 from $1,600 at UBS
GOOGL Alphabet Class A
$1,460.51 /

+21.84 (+1.52%)

09/15/20
Fly Intel: Top five analyst initiations
09/14/20 KeyBanc
Alphabet initiated with an Overweight at KeyBanc
AAPL Apple
$114.60 /

+2.38 (+2.12%)

09/28/20 KeyBanc
Apple content promotion shows importance of Roku's audience, says KeyBanc
09/28/20 Northland
Identiv benefitting as Apple supports NFC, says Northland
09/25/20 Exane BNP Paribas
Exane double upgrades Qualcomm on share gains from Huawei ban
09/23/20 Jefferies
Facebook risk/reward 'remains compelling,' says Jefferies
TCEHY Tencent
$0.00 /

+ (+0.00%)

08/13/20 Benchmark
Tencent price target raised to HK$575 from HK$560 at Benchmark
08/03/20 Morgan Stanley
Sohu.com named a Research Tactical Idea at Morgan Stanley
07/27/20 Barclays
Tencent price target raised to $75 from $63 at Barclays
07/14/20 Citi
Tencent price target raised to HK$649 from HK$541 at Citi
KKR KKR
$34.90 /

+0.96 (+2.83%)

08/05/20 Citi
Citi adds KKR to U.S. Focus List, ups price target to $47.50
07/09/20 Keefe Bruyette
KKR price target raised to $41 from $34 at Keefe Bruyette
06/29/20 Wells Fargo
CyrusOne CEO appointment could reignite sale speculation, says Wells Fargo
06/17/20 Piper Sandler
KKR initiated with an Overweight at Piper Sandler
DIS Disney
$126.41 /

+2.37 (+1.91%)

09/28/20 Benchmark
Benchmark says market continues overestimating Netflix's 'sustainable dominance'
09/24/20 Needham
Disney Q4 revenue, earnings outlook lowered at Needham
09/14/20 Jefferies
ESPN deal positive for both Caesars and DraftKings, says Jefferies
09/14/20 Evercore ISI
ESPN deal could add up to material dollars for DraftKings, says Evercore
SNE Symbol now SONY
$77.34 /

+0.05 (+0.06%)

09/23/20 Baird
Demand for PS5, Xbox Series X continues to look 'strong,' says Baird
09/23/20 Loop Capital
GameStop price target raised to $9 from $6 at Loop Capital
09/21/20 Jefferies
Microsoft 'doubling down on gaming' with deal, says Jefferies
09/21/20 Cowen
Bethesda deal could alter competition between Microsoft and Sony, says Cowen

TODAY'S FREE FLY STORIES

Earnings
Exicure reports Q1 EPS (14c), consensus (12c) » 16:17
05/12/21
05/12
16:17
05/12/21
16:17
XCUR

Exicure

$1.68 /

-0.07 (-4.00%)

Reports Q1 revenue $997M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
XCUR Exicure
$1.68 /

-0.07 (-4.00%)

XCUR Exicure
$1.68 /

-0.07 (-4.00%)

12/18/20 BMO Capital
Exicure initiated with an Outperform at BMO Capital
XCUR Exicure
$1.68 /

-0.07 (-4.00%)

Earnings
Acutus Medical sees FY21 revenue $22M-$30M , consensus $24.49M  16:17
05/12/21
05/12
16:17
05/12/21
16:17
AFIB

Acutus Medical

$11.64 /

-0.29 (-2.43%)

 
ShowHide Related Items >><<
AFIB Acutus Medical
$11.64 /

-0.29 (-2.43%)

AFIB Acutus Medical
$11.64 /

-0.29 (-2.43%)

03/19/21 Canaccord
Acutus Medical price target lowered to $16 from $30 at Canaccord
03/19/21 William Blair
Acutus Medical downgraded to Market Perform from Outperform at William Blair
03/19/21 JPMorgan
Acutus Medical downgraded to Neutral with $19 target at JPMorgan
03/19/21 JPMorgan
Acutus Medical downgraded to Neutral from Overweight at JPMorgan
AFIB Acutus Medical
$11.64 /

-0.29 (-2.43%)

  • 06
    Aug
AFIB Acutus Medical
$11.64 /

-0.29 (-2.43%)

AFIB Acutus Medical
$11.64 /

-0.29 (-2.43%)

Earnings
Coherent reports Q2 adjusted EPS $1.42, consensus $1.15 » 16:16
05/12/21
05/12
16:16
05/12/21
16:16
COHR

Coherent

$254.71 /

-5.125 (-1.97%)

Reports Q2 revenue $374M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
COHR Coherent
$254.71 /

-5.125 (-1.97%)

COHR Coherent
$254.71 /

-5.125 (-1.97%)

05/07/21 Northland
II-VI upgraded to Outperform from Market Perform at Northland
03/26/21 Northland
NeoPhotonics deal 'makes more sense than ever' for Lumentum, says Northland
03/26/21 Cowen
II-VI weakness on deal announcement a buying opportunity, says Cowen
03/26/21 B. Riley Securities
II-VI upgraded to Buy from Neutral at B. Riley Securities
COHR Coherent
$254.71 /

-5.125 (-1.97%)

COHR Coherent
$254.71 /

-5.125 (-1.97%)

COHR Coherent
$254.71 /

-5.125 (-1.97%)

Hot Stocks
Alexion, Caelum announce CAEL-101 data presentations at EHA 2021 » 16:16
05/12/21
05/12
16:16
05/12/21
16:16
ALXN

Alexion

$172.10 /

+0.8 (+0.47%)

Caelum Biosciences and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ALXN Alexion
$172.10 /

+0.8 (+0.47%)

ALXN Alexion
$172.10 /

+0.8 (+0.47%)

05/05/21
Fly Intel: Top five analyst upgrades
05/05/21 Oppenheimer
Alexion upgraded to Outperform from Perform at Oppenheimer
05/03/21 SVB Leerink
Alexion price target raised to $173 from $156 at SVB Leerink
04/30/21 Wedbush
Alexion's Q1 report 'uneventful' after FTC grants deal clearance, says Wedbush
ALXN Alexion
$172.10 /

+0.8 (+0.47%)

ALXN Alexion
$172.10 /

+0.8 (+0.47%)

ALXN Alexion
$172.10 /

+0.8 (+0.47%)

Earnings
Spruce Biosciences reports Q1 EPS (42c), consensus (42c) » 16:16
05/12/21
05/12
16:16
05/12/21
16:16
SPRB

Spruce Biosciences

$14.80 /

+0.16 (+1.09%)

"Throughout the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SPRB Spruce Biosciences
$14.80 /

+0.16 (+1.09%)

SPRB Spruce Biosciences
$14.80 /

+0.16 (+1.09%)

04/26/21 Credit Suisse
Spruce Biosciences assumed with an Outperform at Credit Suisse
11/03/20
Fly Intel: Top five analyst initiations
11/03/20 SVB Leerink
SVB Leerink bullish on Spruce Biosciences, initiates with an Outperform
11/03/20 SVB Leerink
Spruce Biosciences initiated with an Outperform at SVB Leerink
SPRB Spruce Biosciences
$14.80 /

+0.16 (+1.09%)

  • 09
    Oct
SPRB Spruce Biosciences
$14.80 /

+0.16 (+1.09%)

Technical Analysis
NYSE market internals summary » 16:16
05/12/21
05/12
16:16
05/12/21
16:16
$NYE

NYSE Market Internals

/

+

Volume was above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$NYE NYSE Market Internals
/

+

Earnings
Billtrust sees FY21 revenue $160M-$166M, consensus $125.59M » 16:15
05/12/21
05/12
16:15
05/12/21
16:15
BTRS

Billtrust

$12.60 /

-0.8 (-5.97%)

Sees FY21 adjusted EBITDA…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BTRS Billtrust
$12.60 /

-0.8 (-5.97%)

BTRS Billtrust
$12.60 /

-0.8 (-5.97%)

04/30/21 JPMorgan
Billtrust initiated with a Neutral at JPMorgan
04/22/21 Cowen
Billtrust initiated with an Outperform at Cowen
03/18/21 KeyBanc
Billtrust initiated with an Overweight at KeyBanc
03/10/21 Needham
Billtrust initiated with a Buy at Needham
BTRS Billtrust
$12.60 /

-0.8 (-5.97%)

BTRS Billtrust
$12.60 /

-0.8 (-5.97%)

Earnings
Soliton reports Q1 EPS (25c), consensus (25c) » 16:15
05/12/21
05/12
16:15
05/12/21
16:15
SOLY

Soliton

$22.38 /

+0.06 (+0.27%)

Total cash, cash…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SOLY Soliton
$22.38 /

+0.06 (+0.27%)

SOLY Soliton
$22.38 /

+0.06 (+0.27%)

05/11/21 Maxim
Soliton downgraded to Hold from Buy at Maxim
05/10/21 Maxim
Soliton downgraded to Hold from Buy at Maxim
03/08/21 Maxim
Soliton's multiple 2021 trials to expand its pipeline, says Maxim
02/08/21 Maxim
Soliton price target raised to $25 from $22 at Maxim
SOLY Soliton
$22.38 /

+0.06 (+0.27%)

  • 26
    Jun
SOLY Soliton
$22.38 /

+0.06 (+0.27%)

Earnings
Datto sees FY21 revenue $594M-$600M, consensus $587.07M » 16:15
05/12/21
05/12
16:15
05/12/21
16:15
MSP

Datto

$24.40 /

-0.52 (-2.09%)

Sees FY21 adjusted EBITDA…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MSP Datto
$24.40 /

-0.52 (-2.09%)

MSP Datto
$24.40 /

-0.52 (-2.09%)

03/15/21 Credit Suisse
Datto assumed with a Neutral at Credit Suisse
03/12/21 Mizuho
Datto price target lowered to $31 from $35 at Mizuho
03/09/21 BMO Capital
Datto price target lowered to $27 from $38 at BMO Capital
03/08/21 RBC Capital
Datto price target lowered to $34 from $39 at RBC Capital
MSP Datto
$24.40 /

-0.52 (-2.09%)

  • 21
    Oct
MSP Datto
$24.40 /

-0.52 (-2.09%)

MSP Datto
$24.40 /

-0.52 (-2.09%)

Earnings
Coupang reports Q1 EPS (68c) vs. ($5.74) last year. » 16:14
05/12/21
05/12
16:14
05/12/21
16:14
CPNG

Coupang

$35.29 /

-0.99 (-2.73%)

Reports Q1 revenue $4.21B…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CPNG Coupang
$35.29 /

-0.99 (-2.73%)

CPNG Coupang
$35.29 /

-0.99 (-2.73%)

04/07/21 JPMorgan
Coupang initiated with a Neutral at JPMorgan
04/05/21 Deutsche Bank
Coupang initiated with a Hold at Deutsche Bank
04/05/21 Mizuho
Coupang initiated with a Neutral at Mizuho
04/05/21 Goldman Sachs
Coupang initiated with a Buy at Goldman Sachs
  • 11
    Mar
CPNG Coupang
$35.29 /

-0.99 (-2.73%)

CPNG Coupang
$35.29 /

-0.99 (-2.73%)

CPNG Coupang
$35.29 /

-0.99 (-2.73%)

Earnings
Acutus Medical sees Q2 revenue $3.8M-$5M, consensus $4.56M  16:14
05/12/21
05/12
16:14
05/12/21
16:14
AFIB

Acutus Medical

$11.64 /

-0.29 (-2.43%)

 
ShowHide Related Items >><<
AFIB Acutus Medical
$11.64 /

-0.29 (-2.43%)

AFIB Acutus Medical
$11.64 /

-0.29 (-2.43%)

03/19/21 Canaccord
Acutus Medical price target lowered to $16 from $30 at Canaccord
03/19/21 William Blair
Acutus Medical downgraded to Market Perform from Outperform at William Blair
03/19/21 JPMorgan
Acutus Medical downgraded to Neutral with $19 target at JPMorgan
03/19/21 JPMorgan
Acutus Medical downgraded to Neutral from Overweight at JPMorgan
AFIB Acutus Medical
$11.64 /

-0.29 (-2.43%)

  • 06
    Aug
AFIB Acutus Medical
$11.64 /

-0.29 (-2.43%)

AFIB Acutus Medical
$11.64 /

-0.29 (-2.43%)

Earnings
Datto sees Q2 revenue $146M-$148M, consensus $142.4M » 16:14
05/12/21
05/12
16:14
05/12/21
16:14
MSP

Datto

$24.38 /

-0.54 (-2.17%)

Sees Q2 adjusted EBITDA…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MSP Datto
$24.38 /

-0.54 (-2.17%)

MSP Datto
$24.38 /

-0.54 (-2.17%)

03/15/21 Credit Suisse
Datto assumed with a Neutral at Credit Suisse
03/12/21 Mizuho
Datto price target lowered to $31 from $35 at Mizuho
03/09/21 BMO Capital
Datto price target lowered to $27 from $38 at BMO Capital
03/08/21 RBC Capital
Datto price target lowered to $34 from $39 at RBC Capital
MSP Datto
$24.38 /

-0.54 (-2.17%)

  • 21
    Oct
MSP Datto
$24.38 /

-0.54 (-2.17%)

MSP Datto
$24.38 /

-0.54 (-2.17%)

Earnings
Ramaco Resources reports Q1 EPS 10c, consensus 0c » 16:14
05/12/21
05/12
16:14
05/12/21
16:14
METC

Ramaco Resources

$4.21 /

-0.17 (-3.88%)

Reports Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
METC Ramaco Resources
$4.21 /

-0.17 (-3.88%)

METC Ramaco Resources
$4.21 /

-0.17 (-3.88%)

02/23/21 B. Riley Securities
Ramaco Resources price target raised to $9 from $8 at B. Riley Securities
02/22/21 Benchmark
Ramaco Resources assumed with a Buy at Benchmark
12/17/20 BMO Capital
Ramaco Resources downgraded to Market Perform from Outperform at BMO Capital
METC Ramaco Resources
$4.21 /

-0.17 (-3.88%)

Earnings
Billtrust reports Q1 EPS (16c), consensus (4c) » 16:14
05/12/21
05/12
16:14
05/12/21
16:14
BTRS

Billtrust

$12.60 /

-0.8 (-5.97%)

Reports Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BTRS Billtrust
$12.60 /

-0.8 (-5.97%)

BTRS Billtrust
$12.60 /

-0.8 (-5.97%)

04/30/21 JPMorgan
Billtrust initiated with a Neutral at JPMorgan
04/22/21 Cowen
Billtrust initiated with an Outperform at Cowen
03/18/21 KeyBanc
Billtrust initiated with an Overweight at KeyBanc
03/10/21 Needham
Billtrust initiated with a Buy at Needham
BTRS Billtrust
$12.60 /

-0.8 (-5.97%)

Earnings
Montrose Environmental backs FY21 revenue growth view 20% » 16:14
05/12/21
05/12
16:14
05/12/21
16:14
MEG

Montrose Environmental

$54.23 /

-0.74 (-1.35%)

Consensus $390.14M.…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MEG Montrose Environmental
$54.23 /

-0.74 (-1.35%)

MEG Montrose Environmental
$54.23 /

-0.74 (-1.35%)

04/21/21 JPMorgan
Montrose Environmental initiated with a Neutral at JPMorgan
04/06/21 Stifel
Montrose Environmental price target raised to $63 from $51 at Stifel
03/26/21 Morgan Stanley
Montrose Environmental initiated with an Equal Weight at Morgan Stanley
03/25/21 Needham
Montrose Environmental price target raised to $50 from $35 at Needham
MEG Montrose Environmental
$54.23 /

-0.74 (-1.35%)

  • 25
    Nov
  • 23
    Jul
Earnings
Datto reports Q1 EPS 18c, consensus 17c » 16:14
05/12/21
05/12
16:14
05/12/21
16:14
MSP

Datto

$24.32 /

-0.6 (-2.41%)

Reports Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MSP Datto
$24.32 /

-0.6 (-2.41%)

MSP Datto
$24.32 /

-0.6 (-2.41%)

03/15/21 Credit Suisse
Datto assumed with a Neutral at Credit Suisse
03/12/21 Mizuho
Datto price target lowered to $31 from $35 at Mizuho
03/09/21 BMO Capital
Datto price target lowered to $27 from $38 at BMO Capital
03/08/21 RBC Capital
Datto price target lowered to $34 from $39 at RBC Capital
MSP Datto
$24.32 /

-0.6 (-2.41%)

  • 21
    Oct
MSP Datto
$24.32 /

-0.6 (-2.41%)

MSP Datto
$24.32 /

-0.6 (-2.41%)

Earnings
Compass sees FY21 revenue $5.35B-$5.55B, consensus $5B » 16:13
05/12/21
05/12
16:13
05/12/21
16:13
COMP

Compass

$14.26 /

-1.13 (-7.34%)

Sees FY21 adjusted EBITDA…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
COMP Compass
$14.26 /

-1.13 (-7.34%)

COMP Compass
$14.26 /

-1.13 (-7.34%)

04/26/21
Fly Intel: Top five analyst initiations
04/26/21 Morgan Stanley
Compass initiated with an Overweight at Morgan Stanley
04/26/21 Oppenheimer
Compass initiated with an Outperform at Oppenheimer
04/26/21 Loop Capital
Compass initiated with a Hold at Loop Capital
COMP Compass
$14.26 /

-1.13 (-7.34%)

  • 01
    Apr
COMP Compass
$14.26 /

-1.13 (-7.34%)

COMP Compass
$14.26 /

-1.13 (-7.34%)

COMP Compass
$14.26 /

-1.13 (-7.34%)

Earnings
Montrose Environmental reports Q1 EPS (62c), consensus (8c) » 16:13
05/12/21
05/12
16:13
05/12/21
16:13
MEG

Montrose Environmental

$54.23 /

-0.74 (-1.35%)

Reports Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MEG Montrose Environmental
$54.23 /

-0.74 (-1.35%)

MEG Montrose Environmental
$54.23 /

-0.74 (-1.35%)

04/21/21 JPMorgan
Montrose Environmental initiated with a Neutral at JPMorgan
04/06/21 Stifel
Montrose Environmental price target raised to $63 from $51 at Stifel
03/26/21 Morgan Stanley
Montrose Environmental initiated with an Equal Weight at Morgan Stanley
03/25/21 Needham
Montrose Environmental price target raised to $50 from $35 at Needham
MEG Montrose Environmental
$54.23 /

-0.74 (-1.35%)

  • 25
    Nov
  • 23
    Jul
Earnings
Amwell sees FY21 revenue $260M-$270M, consensus $266.21M » 16:13
05/12/21
05/12
16:13
05/12/21
16:13
AMWL

Amwell

$12.87 /

+0.17 (+1.34%)

Sees AMG visit volume…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AMWL Amwell
$12.87 /

+0.17 (+1.34%)

AMWL Amwell
$12.87 /

+0.17 (+1.34%)

05/04/21 Piper Sandler
Teladoc closed down 5% on three year old 'news,' says Piper Sandler
05/03/21 Cantor Fitzgerald
Teladoc competitive loss a gain for Amwell, says Cantor Fitzgerald
04/26/21 Piper Sandler
Piper Sandler 'incrementally bullish' on Amwell, Teladoc, 1Life
04/16/21 KeyBanc
Amwell initiated with a Sector Weight at KeyBanc
AMWL Amwell
$12.87 /

+0.17 (+1.34%)

  • 15
    Jan
  • 17
    Sep
AMWL Amwell
$12.87 /

+0.17 (+1.34%)

AMWL Amwell
$12.87 /

+0.17 (+1.34%)

Recommendations
Stephens says Wendy's remains a 2021 Best Idea after 'beat and raise' report » 16:13
05/12/21
05/12
16:13
05/12/21
16:13
WEN

Wendy's

$22.50 /

-0.3 (-1.32%)

Stephens analyst James…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WEN Wendy's
$22.50 /

-0.3 (-1.32%)

WEN Wendy's
$22.50 /

-0.3 (-1.32%)

14:45 Today Wedbush
Wedbush ups Wendy's price target to $28.50 following quarterly results
04/12/21 JPMorgan
Wendy's price target raised to $27 from $25 at JPMorgan
03/24/21 Wedbush
Wendy's added to Best Ideas List at Wedbush
03/22/21
Fly Intel: Top five analyst downgrades
WEN Wendy's
$22.50 /

-0.3 (-1.32%)

WEN Wendy's
$22.50 /

-0.3 (-1.32%)

WEN Wendy's
$22.50 /

-0.3 (-1.32%)

WEN Wendy's
$22.50 /

-0.3 (-1.32%)

Earnings
Acutus Medical reports Q1 EPS 97c, consensus (81c) » 16:13
05/12/21
05/12
16:13
05/12/21
16:13
AFIB

Acutus Medical

$11.60 /

-0.33 (-2.77%)

Reports Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AFIB Acutus Medical
$11.60 /

-0.33 (-2.77%)

AFIB Acutus Medical
$11.60 /

-0.33 (-2.77%)

03/19/21 Canaccord
Acutus Medical price target lowered to $16 from $30 at Canaccord
03/19/21 William Blair
Acutus Medical downgraded to Market Perform from Outperform at William Blair
03/19/21 JPMorgan
Acutus Medical downgraded to Neutral with $19 target at JPMorgan
03/19/21 JPMorgan
Acutus Medical downgraded to Neutral from Overweight at JPMorgan
AFIB Acutus Medical
$11.60 /

-0.33 (-2.77%)

  • 06
    Aug
AFIB Acutus Medical
$11.60 /

-0.33 (-2.77%)

AFIB Acutus Medical
$11.60 /

-0.33 (-2.77%)

Earnings
Amwell reports Q1 EPS (16c), consensus (19c) » 16:12
05/12/21
05/12
16:12
05/12/21
16:12
AMWL

Amwell

$12.87 /

+0.17 (+1.34%)

Reports Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AMWL Amwell
$12.87 /

+0.17 (+1.34%)

AMWL Amwell
$12.87 /

+0.17 (+1.34%)

05/04/21 Piper Sandler
Teladoc closed down 5% on three year old 'news,' says Piper Sandler
05/03/21 Cantor Fitzgerald
Teladoc competitive loss a gain for Amwell, says Cantor Fitzgerald
04/26/21 Piper Sandler
Piper Sandler 'incrementally bullish' on Amwell, Teladoc, 1Life
04/16/21 KeyBanc
Amwell initiated with a Sector Weight at KeyBanc
AMWL Amwell
$12.87 /

+0.17 (+1.34%)

  • 15
    Jan
  • 17
    Sep
AMWL Amwell
$12.87 /

+0.17 (+1.34%)

AMWL Amwell
$12.87 /

+0.17 (+1.34%)

Earnings
Compass sees Q2 revenue $1.5B-$1.6B, consensus $1.27B » 16:12
05/12/21
05/12
16:12
05/12/21
16:12
COMP

Compass

$14.25 /

-1.14 (-7.41%)

Sees Q2 adjusted EBITDA…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
COMP Compass
$14.25 /

-1.14 (-7.41%)

COMP Compass
$14.25 /

-1.14 (-7.41%)

04/26/21
Fly Intel: Top five analyst initiations
04/26/21 Morgan Stanley
Compass initiated with an Overweight at Morgan Stanley
04/26/21 Oppenheimer
Compass initiated with an Outperform at Oppenheimer
04/26/21 Loop Capital
Compass initiated with a Hold at Loop Capital
COMP Compass
$14.25 /

-1.14 (-7.41%)

  • 01
    Apr
COMP Compass
$14.25 /

-1.14 (-7.41%)

COMP Compass
$14.25 /

-1.14 (-7.41%)

COMP Compass
$14.25 /

-1.14 (-7.41%)

Hot Stocks
Boot Barn sees FY22 new unit growth of 10% » 16:12
05/12/21
05/12
16:12
05/12/21
16:12
BOOT

Boot Barn

$67.43 /

-5.03 (-6.94%)

The company is not…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BOOT Boot Barn
$67.43 /

-5.03 (-6.94%)

BOOT Boot Barn
$67.43 /

-5.03 (-6.94%)

02/10/21 Cowen
Boot Barn price target raised to $68 from $65 at Cowen
01/26/21 Jefferies
Boot Barn price target raised to $72 from $68 at Jefferies
01/26/21 Craig-Hallum
Boot Barn price target raised to $54 from $48 at Craig-Hallum
01/26/21 William Blair
Boot Barn valuation remains 'compelling,' says William Blair
BOOT Boot Barn
$67.43 /

-5.03 (-6.94%)

BOOT Boot Barn
$67.43 /

-5.03 (-6.94%)

BOOT Boot Barn
$67.43 /

-5.03 (-6.94%)

Earnings
Relmada Therapeutics reports Q1 EPS ($1.34), consensus ($1.39) » 16:12
05/12/21
05/12
16:12
05/12/21
16:12
RLMD

Relmada Therapeutics

$33.70 /

-1.32 (-3.77%)

"We continue to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RLMD Relmada Therapeutics
$33.70 /

-1.32 (-3.77%)

RLMD Relmada Therapeutics
$33.70 /

-1.32 (-3.77%)

10/28/20 Goldman Sachs
Relmada Therapeutics downgraded to Neutral from Buy at Goldman Sachs
07/13/20 Oppenheimer
Relmada Therapeutics initiated with an Outperform at Oppenheimer
05/27/20 Goldman Sachs
Goldman says Relmada clearance for Phase 3 supports REL-1017 safety, efficacy
RLMD Relmada Therapeutics
$33.70 /

-1.32 (-3.77%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.